We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+15.6%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$8.4B
AUM Growth
+$1.66B
Cap. Flow
+$1.33B
Cap. Flow %
15.85%
Top 10 Hldgs %
61.33%
Holding
510
New
182
Increased
113
Reduced
52
Closed
146

Top Buys

Rank Stock Value
1
AGIO icon
Agios Pharmaceuticals
AGIO
+$79.7M
2
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$74.4M
3
KVUE icon
Kenvue
KVUE
+$65.3M
4
ELF icon
e.l.f. Beauty
ELF
+$51.7M
5
GSK icon
GSK
GSK
+$46.6M

Top Sells

Rank Stock Value
1
TVTX icon
Travere Therapeutics
TVTX
+$96.3M
2
EXAS
Exact Sciences
EXAS
+$56.4M
3
PTCT icon
PTC Therapeutics
PTCT
+$34.5M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$28M
5
MDB icon
MongoDB
MDB
+$23M

Sector Composition

Rank Sector Weight
1 Healthcare 32.56%
2 Technology 5.44%
3 Consumer Discretionary 5.13%
4 Consumer Staples 2.69%
5 Communication Services 1.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STX icon
126
Seagate
STX
$193B
$5.4M 0.06%
+19,592
New +$5.08M
WWW icon
127
Wolverine World Wide
WWW
$1.56B
$5.17M 0.06%
285,000
+79,624
+39% +$1.61M
MCD icon
128
McDonald's
MCD
$196B
$5.17M 0.06%
16,916
-6,854
-29% -$2.1M
INTC icon
129
Intel
INTC
$503B
$4.54M 0.05%
122,936
+50,136
+69% +$1.89M
H icon
130
Hyatt Hotels
H
$16.9B
$4.41M 0.05%
27,533
-26,568
-49% -$4.07M
CRBP icon
131
Corbus Pharmaceuticals
CRBP
$180M
$4.36M 0.05%
536,000
+344,000
+179% +$4.25M
GROY.WS icon
132
Gold Royalty Corp Warrants
GROY.WS
$157M
$4.36M 0.05%
2,200,000
– –
ULTA icon
133
Ulta Beauty
ULTA
$23.2B
$4.13M 0.05%
6,831
-13,435
-66% -$7.39M
LOW icon
134
Lowe's Companies
LOW
$122B
$4.05M 0.05%
16,789
+1,073
+7% +$258K
LEVI icon
135
Levi Strauss
LEVI
$9.35B
$3.84M 0.05%
185,000
+18,556
+11% +$400K
ARAY icon
136
Accuray
ARAY
$33.8M
$3.71M 0.04%
4,500,000
+1,176,000
+35% +$1.47M
KYNB
137
Kyntra Bio
KYNB
$28.3M
$3.51M 0.04%
400,000
+22,000
+6% +$215K
SE icon
138
Sea Limited
SE
$68B
$3.5M 0.04%
27,400
+5,400
+25% +$800K
RBLX icon
139
Roblox
RBLX
$25.7B
$3.33M 0.04%
41,041
-84,880
-67% -$9.01M
NTRP icon
140
NextTrip
NTRP
$24.5M
$3.23M 0.04%
+1,000,000
New +$3.8M
CNDT icon
141
Conduent
CNDT
$271M
$3.03M 0.04%
1,578,000
+742,000
+89% +$1.63M
MNST icon
142
Monster Beverage
MNST
$92.1B
$2.98M 0.04%
38,912
+5,473
+16% +$392K
STZ icon
143
Constellation Brands
STZ
$22.6B
$2.98M 0.04%
21,600
-678
-3% -$93K
HCA icon
144
HCA Healthcare
HCA
$88.5B
$2.94M 0.03%
+6,288
New +$2.92M
MTCH icon
145
Match Group
MTCH
$8.54B
$2.93M 0.03%
+90,641
New +$2.98M
SMG icon
146
ScottsMiracle-Gro
SMG
$3.61B
$2.91M 0.03%
+49,903
New +$2.8M
VSXY
147
Victoria's Secret
VSXY
$7.43B
$2.89M 0.03%
53,313
-66,687
-56% -$2.65M
ABNB icon
148
Airbnb
ABNB
$90B
$2.81M 0.03%
+20,692
New +$2.58M
MDCX
149
Medicus Pharma
MDCX
$17.4M
$2.77M 0.03%
+1,810,960
New +$3.88M
TSEM icon
150
Tower Semiconductor
TSEM
$25.4B
$2.76M 0.03%
+23,521
New +$2.27M
4 5
6
7 8

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q4 2025 Portfolio in Review

As of Q4 2025, Armistice Capital held 510 positions worth $8.4B, up 25% from $6.74B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Armistice Capital deployed $1.33B of net new capital in Q4 2025, opening 182 new positions and adding to 113 existing holdings. Its largest new stake was Kenvue: 3,992,196 shares worth $68.9M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Travere Therapeutics, an estimated $96.3M trimmed.

  • Armistice Capital's largest Q4 2025 buy was Kenvue: 3,992,196 shares worth $68.9M.
  • Armistice Capital added most to Agios Pharmaceuticals in Q4 2025, an estimated $79.7M increase.
  • Armistice Capital's biggest Q4 2025 reduction was Travere Therapeutics, cutting an estimated $96.3M.
  • Armistice Capital fully exited Exact Sciences in Q4 2025, selling an estimated $56.4M.
  • Armistice Capital's ten largest holdings make up 61% of its $8.4B portfolio in Q4 2025.
  • Armistice Capital opened 182 new positions and closed 146 in Q4 2025.
  • Armistice Capital's portfolio value rose 25% quarter-over-quarter to $8.4B.

Based on Armistice Capital's 13F filing for Q4 2025, filed 17 Feb 2026.